Therapy Vardenafil (Levitra)

This medicine also is part of the substance group of the selective phosphodiesterase inhibitors and develops its effect by reinforcement of the blood flow in the penis vessels.

The active substance Vardenafil (Levitra) is approx. more strongly effective than Sildenafil 9 times. The maximal effect has to be expected 45 minutes after intake. The effect admission starts to judge what to be advantage for Levitra already approx. 20 minutes after taking is. The dosage is 5 or 10 or 20 mg minimumly.

It has to be assumed Levitra comes from the same substance group like Cialis and Viagra that it also has the same side effects and risks since. Levitra can independently be taken by the eating.

Side effects: Headaches, vasodilatation (Flush), rhinitis, nausea, dizziness and dyspepsia are the most frequent side effects.

Contraindications: Nitrates, unchecked Arrythmien, hypotension (low blood pressure), myocardial infarction within the last 90 days, Apoplex (stroke) within the last 6 months, blood pressure lowering an unstable angina pectoris, heavy cardiac insufficiency.

At patients with heart conditions or an Apoplex the taking of Levitra is warned against since it can come to deadly incidents. The danger insists one should inform every treating physician (emergency doctor, emergency service physician, specialist etc.) about the intake of Cialis particularly at a simultaneous intake of nitrates of all articles, in principle. This can be live-saving under circumstances.


These informations may be considered a substitute for a piece of medical advice in no case. The content of health-illness.com doesn't can and may be put into any case to make diagnoses or carry out self medical treatment independently.


Diese Informationen dürfen auf keinen Fall als Ersatz für ärztliche Beratung angesehen werden. Der Inhalt von medhost.de kann und darf auf keinen Fall verwendet werden, um eigenständig Diagnosen zu stellen oder Selbstbehandlung durchzuführen.

Medhost ¦ Startseite - Newsletter - Impressum - Disclaimer - Kontakt - Sprache ¦ Deutsch - English
1999 - 2007 Copyright Promeus AG, Alle Rechte vorbehalten